Tekla Life Sciences Investors reported earnings results for the half year ended March 31, 2023. For the half year, the company reported revenue was USD 1.93 million. Net income was USD 33.8 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.97 USD | +0.15% | +1.33% | -3.64% |
1st Jan change | Capi. | |
---|---|---|
-3.64% | 355M | |
+3.74% | 12.61B | |
+5.50% | 9.01B | |
-3.20% | 5.41B | |
+2.44% | 5.25B | |
+5.63% | 5.19B | |
+14.36% | 4.48B | |
+16.67% | 4.44B | |
+1.53% | 4B | |
+1.56% | 3.75B |
- Stock Market
- Equities
- HQL Stock
- News Abrdn Life Sciences Investors
- Tekla Life Sciences Investors Reports Earnings Results for the Half Year Ended March 31, 2023